These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16625233)

  • 21. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine.
    Lee BC; Doo HK; Ahn SY; Byun SH; Kim SI; Park HK; Hong M; Ha E; Yim SV; Yin C; Leem KH; Ahn YM
    Neurol Res; 2007; 29 Suppl 1():S32-7. PubMed ID: 17359638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women.
    Ramírez-Salazar M; Pérez-Luque E; Fajardo-Araujo M; Garza SM; Malacara JM
    Menopause; 2008; 15(6):1151-6. PubMed ID: 18551086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.
    Scaglioni S; Verduci E; Salvioni M; Biondi ML; Radaelli G; Agostoni C; Giovannini M
    Pediatr Res; 2006 Oct; 60(4):485-9. PubMed ID: 16940242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
    Tönjes A; Scholz M; Loeffler M; Stumvoll M
    Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
    Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
    Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
    Tönjes A; Stumvoll M
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report].
    Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A
    Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
    Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
    Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
    Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
    Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
    J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
    Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
    Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
    Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM
    Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
    Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
    Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
    Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
    Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
    Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.